Promoter holding
64.27%
MP
Mataco Pharmaceutical Pvt Ltd - Due diligence report
A 360° intelligence report on Mataco Pharmaceutical Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and d…
MP
Mataco Pharmaceutical Pvt Ltd
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Mataco Pharmaceutical Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records79/100
Trust Score
Low Risk
Mataco Pharmaceutical Pvt Ltd is assessed as Low Risk with a Trust Score of 79/100. Mataco Pharmaceutical Pvt Ltd is an active private limited indian non-government company incorporated in 1988, operating in the Financial Services sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Mataco Pharmaceutical Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
79/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 50/100 Moderate
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 88/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| GIRDHARI LAL KHEMANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ASHA KEJRIWAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 2 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 50 · Distress 75
Growth signals & trust indicators
Operating for 37+ years.
Distress signals & risk flags
Losses deepening year-on-year.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment61/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view59/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 8 events17 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
31 Mar 2019
Share transfer (FY 2019)
40501.00000000 shares to ASHA KEJRIWAL
Share transfer (FY 2019)
10000.00000000 shares to ASHA KEJRIWAL
01 Sep 2018
Director ceased
AYUSH KEJRIWAL
26 Jun 2007
Director appointed
GIRDHARI LAL KHEMANI (Director)
20 Nov 1995
Director appointed
ASHA KEJRIWAL (Director)
11 Aug 1988
Incorporated
Registered with Roc Kolkata
10
Key Observations
Auto-generated from the data aboveRevenue grew 38% over the last 4 financial year(s).
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
| Company | CIN | Location |
|---|---|---|
| Shri Ambe Punjinvesh Private Limited | U67120MH1995PTC093279 | Mumbai, Maharashtra, India |
| Kamalanidhi Infrastructure Private Limited | U70200WB2010PTC143066 | Kolkata, West Bengal, India |
| Golcha Holdings Private Limited | U65993RJ1987PTC003883 | Jaipur, Rajasthan, India |
| Future Money Financial Services Limited | U65999MH2017PLC294606 | Mumbai, Maharashtra, India |
| Bj Trading Private Limited | U51909WB1997PTC083072 | Kolkata, West Bengal, India |
| Deepanshu Investment Private Limited | U74899DL1989PTC037720 | New Delhi, Delhi, India |
| Policy Adda Insurance Brokers Private Limited | U66000MH2021PTC358796 | Navi Mumbai, Maharashtra, India |
| Narottamka Commercial Company Pvt Ltd | U51494WB1989PTC046452 | West Bengal, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Mataco Pharmaceutical Pvt Ltd before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Mataco Pharmaceutical Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Mataco Pharmaceutical Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 79/100, distress signals and MSME payment-delay disclosures - know whether Mataco Pharmaceutical Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Mataco Pharmaceutical Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Mataco Pharmaceutical Pvt Ltd an active company?
Mataco Pharmaceutical Pvt Ltd has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Mataco Pharmaceutical Pvt Ltd financially healthy?
Mataco Pharmaceutical Pvt Ltd has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.
Should I do business with Mataco Pharmaceutical Pvt Ltd?
Its overall Trust Score is 79/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Mataco Pharmaceutical Pvt Ltd?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Mataco Pharmaceutical Pvt Ltd have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Mataco Pharmaceutical Pvt Ltd up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Mataco Pharmaceutical Pvt Ltd?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
